Lincoln National Corp’s Repligen RGEN Stock Holding History

Lincoln National Corp’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,565	Closed	-$265K	–	1028
2022 Q4	$265K	Buy	+1,565	New	+$284K	0.01%	769

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lincoln National Corp's RGEN Position: Q1 2023 in Review

Lincoln National Corp sold out of Repligen (RGEN) in Q1 2023, closing a stake of 1,565 shares — an estimated $265K sold.

Lincoln National Corp first reported a position in RGEN in Q4 2022 and held it in 1 quarter. The position peaked at $265K in Q4 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

Lincoln National Corp reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
Lincoln National Corp sold 1,565 Repligen shares in Q1 2023, an estimated $265K.
Lincoln National Corp first reported a position in Repligen in Q4 2022 and held it in 1 quarter.
Lincoln National Corp's Repligen position peaked at $265K in Q4 2022.
446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Lincoln National Corp's 13F filing for Q1 2023, filed 2 May 2023.